The Scientist

» neglected tropical diseases

Most Recent

image: New Drug Target for Three Tropical Diseases

New Drug Target for Three Tropical Diseases

By Tracy Vence | August 9, 2016

Researchers efficiently clear mice of the parasites that cause leishmaniasis, Chagas disease, and sleeping sickness by inhibiting the parasites’ kinetoplastid proteasomes.

0 Comments

image: Study: Melioidosis Underreported

Study: Melioidosis Underreported

By Catherine Offord | January 12, 2016

Researchers warn that a poorly understood, life-threatening tropical disease may be killing thousands more people than previously realized.

0 Comments

image: Opinion: Diagnostics for NTDs

Opinion: Diagnostics for NTDs

By Mark Kessel and Joseph Ndung’u | August 25, 2014

Developing treatments for neglected tropical diseases is only half the battle.

0 Comments

image: Are <em>Leishmania</em> Protecting their Sand Fly Hosts?

Are Leishmania Protecting their Sand Fly Hosts?

By Ruth Williams | July 23, 2014

The microbial contents of sand fly stomachs may have important consequences for the spread of leishmaniasis.

0 Comments

image: Genome Digest

Genome Digest

By Tracy Vence | April 24, 2014

What researchers are learning as they sequence, map, and decode species’ genomes

0 Comments

image: Deep Doo-doo

Deep Doo-doo

By Bob Grant | January 4, 2013

An open-access study explores the intricacies of parasite egg distribution and viability in human feces.

0 Comments

image: $785 Million for Tropical Diseases

$785 Million for Tropical Diseases

By Hannah Waters | January 31, 2012

A public-private partnership including 13 pharmaceutical companies pledge more than $785 million to fight neglected tropical diseases.

5 Comments

Popular Now

  1. Two University of Rochester Professors Resign in Protest
  2. Dartmouth Professor Investigated for Sexual Misconduct Retires
  3. Theranos Leaders Indicted For Fraud
    The Nutshell Theranos Leaders Indicted For Fraud

    Federal prosecutors filed criminal charges that allege the company’s promise to revolutionize blood testing swindled investors out of hundreds of millions of dollars and put patients in danger.

  4. Koko the Signing Gorilla Dies at 46